William Blair Has Optimistic Outlook of USPH FY2025 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Research analysts at William Blair increased their FY2025 earnings per share estimates for shares of U.S. Physical Therapy in a research report issued on Wednesday, November 12th. William Blair analyst J. Haase now anticipates that the company will post earnings per share of $2.64 for the year, up from their prior estimate of $2.45. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s FY2026 earnings at $3.03 EPS.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Tuesday, August 22nd. The company reported $0.90 earnings per share (EPS) for the quarter. The business had revenue of $140.66 million during the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%.

A number of other research analysts have also weighed in on the stock. Barrington Research reissued an “outperform” rating and issued a $103.00 target price on shares of U.S. Physical Therapy in a research note on Friday, October 24th. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. Zacks Research raised U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th. JPMorgan Chase & Co. began coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 target price for the company. Finally, Wall Street Zen lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $110.25.

U.S. Physical Therapy Stock Performance

USPH opened at $69.99 on Monday. U.S. Physical Therapy has a twelve month low of $62.77 and a twelve month high of $101.19. The firm has a market capitalization of $1.06 billion, a PE ratio of 30.56, a PEG ratio of 4.41 and a beta of 1.47. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.30. The firm’s 50-day moving average price is $83.95 and its 200 day moving average price is $80.20.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of hedge funds have recently made changes to their positions in USPH. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in U.S. Physical Therapy by 952.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company’s stock valued at $32,000 after purchasing an additional 400 shares during the period. Parallel Advisors LLC grew its stake in shares of U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock valued at $35,000 after buying an additional 213 shares in the last quarter. Cullen Frost Bankers Inc. raised its holdings in shares of U.S. Physical Therapy by 171.8% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after buying an additional 280 shares during the period. EverSource Wealth Advisors LLC lifted its stake in U.S. Physical Therapy by 68.8% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock worth $40,000 after acquiring an additional 192 shares in the last quarter. Finally, Assetmark Inc. lifted its stake in U.S. Physical Therapy by 35.7% during the 2nd quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after acquiring an additional 150 shares in the last quarter.

Insider Buying and Selling at U.S. Physical Therapy

In related news, Director Nancy Ham sold 600 shares of the firm’s stock in a transaction dated Thursday, September 11th. The stock was sold at an average price of $81.71, for a total transaction of $49,026.00. Following the completion of the sale, the director directly owned 1,994 shares of the company’s stock, valued at approximately $162,929.74. This trade represents a 23.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Eric Joseph Williams sold 1,000 shares of the company’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the transaction, the chief operating officer directly owned 25,331 shares in the company, valued at $2,159,467.75. The trade was a 3.80% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 5,061 shares of company stock worth $426,273. Insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 12th. Stockholders of record on Monday, November 17th will be paid a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio is 75.63%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.